AMEX:BDR

Stock Analysis Report

Blonder Tongue Laboratories

Executive Summary

Blonder Tongue Laboratories, Inc., a technology-development and manufacturing company, provides television signal encoding, transcoding, digital transport, and broadband product solutions in the United States.


Snowflake Analysis

Adequate balance sheet and fair value.


Similar Companies

Share Price & News

How has Blonder Tongue Laboratories's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: BDR has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

9.8%

BDR

12.8%

US Communications

12.5%

US Market


1 Year Return

-40.7%

BDR

-28.7%

US Communications

-12.7%

US Market

Return vs Industry: BDR underperformed the US Communications industry which returned -28.7% over the past year.

Return vs Market: BDR underperformed the US Market which returned -12.7% over the past year.


Shareholder returns

BDRIndustryMarket
7 Day9.8%12.8%12.5%
30 Day-10.6%-4.5%-14.7%
90 Day-11.8%-18.9%-21.5%
1 Year-40.7%-40.7%-27.2%-28.7%-10.9%-12.7%
3 Year18.6%18.6%9.6%2.7%12.6%5.4%
5 Year-21.6%-21.6%40.1%25.0%31.9%17.5%

Price Volatility Vs. Market

How volatile is Blonder Tongue Laboratories's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Blonder Tongue Laboratories undervalued compared to its fair value and its price relative to the market?

2.69x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate BDR's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate BDR's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: BDR is good value based on its PE Ratio (2.7x) compared to the Communications industry average (21.6x).

PE vs Market: BDR is good value based on its PE Ratio (2.7x) compared to the US market (13x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate BDR's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: BDR is good value based on its PB Ratio (0.6x) compared to the US Communications industry average (1.3x).


Next Steps

Future Growth

How is Blonder Tongue Laboratories forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

13.2%

Forecasted Tech industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Blonder Tongue Laboratories has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Blonder Tongue Laboratories performed over the past 5 years?

51.1%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: BDR has a high level of non-cash earnings.

Growing Profit Margin: BDR became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: BDR has become profitable over the past 5 years, growing earnings by 51.1% per year.

Accelerating Growth: BDR has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: BDR has become profitable in the last year, making it difficult to compare its past year earnings growth to the Communications industry (-13.2%).


Return on Equity

High ROE: BDR's Return on Equity (21.4%) is considered high.


Next Steps

Financial Health

How is Blonder Tongue Laboratories's financial position?


Financial Position Analysis

Short Term Liabilities: BDR's short term assets ($12.1M) exceed its short term liabilities ($4.7M).

Long Term Liabilities: BDR's short term assets ($12.1M) exceed its long term liabilities ($2.8M).


Debt to Equity History and Analysis

Debt Level: BDR's debt to equity ratio (8%) is considered satisfactory.

Reducing Debt: BDR's debt to equity ratio has reduced from 33.1% to 8% over the past 5 years.


Balance Sheet

Inventory Level: BDR has a high level of physical assets or inventory.

Debt Coverage by Assets: BDR's debt is covered by short term assets (assets are 13.8x debt).


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: BDR is profitable, therefore cash runway is not a concern.

Forecast Cash Runway: BDR is profitable, therefore cash runway is not a concern.


Next Steps

Dividend

What is Blonder Tongue Laboratories's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate BDR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate BDR's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if BDR's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if BDR's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of BDR's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.7yrs

Average management tenure


CEO

Ted Grauch (52yo)

0.17

Tenure

Mr. Edward Rowland Grauch, also known as Ted, has been the Chief Executive Officer at Blonder Tongue Laboratories, Inc. since January 1, 2020. Mr. Grauch has been the President of Blonder Tongue Laboratori ...


Leadership Team

NamePositionTenureCompensationOwnership
Eric Skolnik
Senior VP18.83yrsUS$228.36k0.090% $5.8k
Edward Grauch
President & CEO0.17yrno data1.99% $128.5k
Ronald Alterio
VP of Engineering & CTO1.67yrsno data0.14% $9.0k

1.7yrs

Average Tenure

52yo

Average Age

Experienced Management: BDR's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Anthony Bruno
Independent Director12yrsUS$60.32k2.32% $150.1k
Robert Pallé
Director26.5yrsUS$170.09k27.76% $1.8m
Gary Scharmett
Independent Director22.25yrsUS$56.15k2.96% $190.8k
James Williams
Independent Director26.5yrsUS$54.75k2.39% $154.2k
James Williams
Independent Director5yrsUS$51.55k4.5% $290.4k
Stephen Necessary
Independent Director2.17yrsUS$54.84k0.70% $45.0k
Steven Shea
Independent Chairman4.83yrsUS$84.85k6.72% $433.7k
Charles Dietz
Independent Director8.5yrsUS$59.15k2.47% $159.2k
John Burke
Director0.17yrno datano data

8.5yrs

Average Tenure

63yo

Average Age

Experienced Board: BDR's board of directors are considered experienced (8.5 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 9%.


Top Shareholders

Company Information

Blonder Tongue Laboratories, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Blonder Tongue Laboratories, Inc.
  • Ticker: BDR
  • Exchange: AMEX
  • Founded: 1950
  • Industry: Communications Equipment
  • Sector: Tech
  • Market Cap: US$6.457m
  • Shares outstanding: 9.63m
  • Website: https://www.blondertongue.com

Number of Employees


Location

  • Blonder Tongue Laboratories, Inc.
  • One Jake Brown Road
  • Old Bridge
  • New Jersey
  • 8857
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
BDRAMEX (NYSE MKT LLC)YesCommon StockUSUSDDec 1995

Biography

Blonder Tongue Laboratories, Inc., a technology-development and manufacturing company, provides television signal encoding, transcoding, digital transport, and broadband product solutions in the United States. It offers digital video headend products comprising high definition and SD, MPEG-2, and MPEG-4/H.264 encoders, as well as quadrature phase shift key to quadrature amplitude modulation (QAM) transcoders; digital QAM multiplexers; ATSC/QAM-IP transcoders; and EdgeQAM devices. The company provides its digital video headend products for use by system operators for acquisition, processing, compression, encoding, and management of digital videos. In addition, the company offers analog video headend products, including pre-fabricated headends to accommodate legacy analog television systems, modulators, demodulators, and processors for use by system operators for signal acquisition, processing, and manipulation to create an analog channel lineup for further transmission. Further, it provides hybrid-fiber coax distribution products comprising broadband amplifiers, directional taps, splitters, and wall outlets for coax distribution and fiber optic transmitters, receivers, and couplers. Additionally, the company offers data products to deliver data, video, and voice-over-coaxial in hospitality, multiple dwelling unit, and college campus locations; and test instruments, contract manufacturing and technical services, reception products, and miscellaneous products and services. It serves television broadcasters, cable system operators, and lodging/hospitality video and high-speed Internet system operators, as well as commercial/institutional/enterprise system operators, including educational campus environments, correctional facilities, short and long term health service environments, sports stadiums, and airport terminals through its sales force and stocking distributors. Blonder Tongue Laboratories, Inc. was founded in 1950 and is headquartered in Old Bridge, New Jersey. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/03/30 00:31
End of Day Share Price2020/03/27 00:00
Earnings2019/09/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.